Risk scores to facilitate preoperative prediction of transfusion and large volume blood transfusion associated with adult cardiac surgery

British Journal of Anaesthesia

Volumn 114, Issue 5, 2015, Pages 757-766

  Goudie, R ^a,b   Sterne, J A C ^a   Verheyden, V ^c   Bhabra, M ^d   Ranucci, M ^e   Murphy, G J ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d NEW CROSS HOSPITAL   (United Kingdom)

^e IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

blood transfusion; cardiac anaesthesia

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD VOLUME; CLINICAL DECISION MAKING; CONFIDENCE INTERVAL; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; UNITED KINGDOM; VALIDATION STUDY; AREA UNDER THE CURVE; BLOOD TRANSFUSION; CLINICAL TRIAL; COHORT ANALYSIS; MIDDLE AGED; MULTICENTER STUDY; OPERATIVE BLOOD LOSS; PREOPERATIVE CARE; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; AREA UNDER CURVE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; COHORT STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84928920409     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu483     Document Type: Article

References (24)

1. Wells AW, Llewelyn CA, Casbard A, et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med 2009; 19: 315-28
2. US Department of Health and Human Services. The 2007 Nationwide Blood Collection and Utilization Survey Report. Washington, DC: Department of Health and Human Services, 2007
3. Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004; 44: 1453-62
4. Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical re-exploration after cardiac operations: why a worse outcome? Ann Thorac Surg 2008; 86: 1557-62
5. Carless PA, HenryDA, Moxey AJ, O'Connell D, Brown T, FergussonDA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010; 4: CD001888
6. Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; 3: CD001886
7. Murphy MF, Murphy GJ, Gill R, Herbertson M, Allard S, Grant-Casey J. 2011 Audit of Blood Transfusion in Adult Cardiac Surgery. Oxford: National Comparative Audit of Blood Transfusion, National Health Service Blood and Transplant, 2013
8. Bennett-Guerrero E, Zhao Y, O'Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010; 304: 1568-75
9. Bridgewater B, Keogh B, Kinsman R, Walton P. Sixth National Adult Cardiac Surgical Database Report 2008. Improving outcomes for patients. Oxfordshire: Dendrite Clinical Systems Ltd, 2008
10. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82
11. Ranucci M, Castelvecchio S, Frigiola A, Scolletta S, Giomarelli P, Biagioli B. Predicting transfusions in cardiac surgery: the easier, the better: the Transfusion Risk and Clinical Knowledge score. Vox Sang 2009; 96: 324-32
12. Algamdi AA, Davis A, Brister S, Corey P, Logan A. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs. Transfusion 2006; 46: 1120-9
13. Vuylsteke A, Pagel C, Gerrard C, et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011; 39: 924-30
14. Karkouti K, O'Farrell R, Yau TM, Beattie WS. Reducing Bleeding in Cardiac Surgery Research Group. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth 2006; 53: 781-94
15. Karkouti K, WijeysunderaDN, BeattieWS, et al.Reducing Bleeding in Cardiac Surgery (RBC) Research Group. Variabilityand predictability of large-volume red blood cell transfusion in cardiac surgery: a multicentre study. Transfusion 2007; 47: 2081-8
16. Royston P. Multiple imputation of missing values: update of ice. The Stata Journal 2005; 5: 527-36
17. Royston P, Sauerbrei W. Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. J R Stat Soc Ser A Stat Soc 1999; 162: 71-94
18. Royston P, ParmarMKB, Sylvester R. Constructionand validation of a prognostic model across several studies, with an application in superficial bladder cancer. Stat Med 2004; 23: 907-26
19. Sterne JAC (ed). Meta-Analysis in Stata: An Updated Collection From the Stata Journal. College Station, TX: Stata Press, 2009
20. Vergouwe Y, Royston P, Moons KGM, Altman DG. Development and validation ofapredictionmodelwith missing predictordata:apractical approach. J Clin Epidemiol 2010; 63: 205-14
21. Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 2009; 28: 57
22. Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31
23. Beattie WS, Karkouti K. The post-BART anti-fibrinolytic dilemma? J Cardiothorac Vasc Anesth 2011; 25: 3-5
24. Karkouti K, von Heymann C, Jespersen CM, et al. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. J Thorac Cardiovasc Surg 2013; 146: 927-39